Handgrip Strength Is Associated with Poorer Cognitive Functioning in Aging Americans.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 20 7 2019
medline: 10 10 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

Measures of handgrip strength may show promise for detecting cognitive erosion during aging. To determine the associations between lower handgrip strength and poorer cognitive functioning for aging Americans. There were 13,828 participants aged at least 50 years from the 2006 wave of the Health and Retirement Study included and followed biennially for 8 years. Handgrip strength was assessed with a hand-held dynamometer and cognitive functioning was assessed with a modified version of the Mini-Mental State Examination. Participants aged <65 years with scores 7- 11 had a mild cognitive impairment, ≤6 had a severe cognitive impairment, and ≤11 had any cognitive impairment. Respondents aged ≥65 years with scores 8- 10 had a mild cognitive impairment, ≤7 had a severe cognitive impairment, and ≤10 had any cognitive impairment. Separate covariate-adjusted multilevel logistic models examined the associations between lower handgrip strength and any or severe cognitive impairment. A multilevel ordered logit model analyzed the association between lower handgrip strength and poorer cognitive functioning. Every 5-kg lower handgrip strength was associated with 1.10 (95% confidence interval (CI): 1.04, 1.15) and 1.18 (CI: 1.04, 1.32) greater odds for any and severe cognitive impairment, respectively. Similarly, every 5-kg lower handgrip strength was associated with 1.10 (CI: 1.05, 1.14) greater odds for poorer cognitive functioning. Measurement of handgrip strength is a simple, risk-stratifying method for helping healthcare providers determine poorer cognitive functioning. Interventions aiming to prevent or delay cognitive dysfunction should also implement measures of handgrip strength as an assessment tool for determining efficacy.

Sections du résumé

BACKGROUND
Measures of handgrip strength may show promise for detecting cognitive erosion during aging.
OBJECTIVE
To determine the associations between lower handgrip strength and poorer cognitive functioning for aging Americans.
METHODS
There were 13,828 participants aged at least 50 years from the 2006 wave of the Health and Retirement Study included and followed biennially for 8 years. Handgrip strength was assessed with a hand-held dynamometer and cognitive functioning was assessed with a modified version of the Mini-Mental State Examination. Participants aged <65 years with scores 7- 11 had a mild cognitive impairment, ≤6 had a severe cognitive impairment, and ≤11 had any cognitive impairment. Respondents aged ≥65 years with scores 8- 10 had a mild cognitive impairment, ≤7 had a severe cognitive impairment, and ≤10 had any cognitive impairment. Separate covariate-adjusted multilevel logistic models examined the associations between lower handgrip strength and any or severe cognitive impairment. A multilevel ordered logit model analyzed the association between lower handgrip strength and poorer cognitive functioning.
RESULTS
Every 5-kg lower handgrip strength was associated with 1.10 (95% confidence interval (CI): 1.04, 1.15) and 1.18 (CI: 1.04, 1.32) greater odds for any and severe cognitive impairment, respectively. Similarly, every 5-kg lower handgrip strength was associated with 1.10 (CI: 1.05, 1.14) greater odds for poorer cognitive functioning.
CONCLUSIONS
Measurement of handgrip strength is a simple, risk-stratifying method for helping healthcare providers determine poorer cognitive functioning. Interventions aiming to prevent or delay cognitive dysfunction should also implement measures of handgrip strength as an assessment tool for determining efficacy.

Identifiants

pubmed: 31322562
pii: JAD190042
doi: 10.3233/JAD-190042
pmc: PMC9483826
mid: NIHMS1836049
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1187-1196

Subventions

Organisme : NIA NIH HHS
ID : P30 AG053760
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG044424
Pays : United States

Références

Int Psychogeriatr. 2017 Dec;29(12):1965-1977
pubmed: 28829003
J Frailty Aging. 2019;8(1):7-9
pubmed: 30734824
Can J Plast Surg. 2010 Spring;18(1):e10-4
pubmed: 21358861
Psychol Aging. 2001 Dec;16(4):588-99
pubmed: 11766914
J Appl Physiol (1985). 2003 Oct;95(4):1361-9
pubmed: 12626484
J Hand Ther. 2004 Jul-Sep;17(3):364-7
pubmed: 15273677
Front Hum Neurosci. 2016 Nov 25;10:596
pubmed: 27932964
Clin Geriatr Med. 2013 Nov;29(4):737-52
pubmed: 24094294
Ergonomics. 1981 Jan;24(1):21-36
pubmed: 7227358
Int J Epidemiol. 2014 Apr;43(2):576-85
pubmed: 24671021
World J Psychiatry. 2016 Mar 22;6(1):54-65
pubmed: 27014598
Psychol Aging. 1998 Sep;13(3):486-500
pubmed: 9793123
Neurology. 2013 May 7;80(19):1778-83
pubmed: 23390181
Ageing Res Rev. 2017 May;35:112-123
pubmed: 28189666
J Am Geriatr Soc. 2013 Mar;61(3):396-402
pubmed: 23414481
NCHS Data Brief. 2015 Jan;(179):1-8
pubmed: 25633238
Age Ageing. 2015 May;44(3):445-51
pubmed: 25468013
J Gerontol A Biol Sci Med Sci. 2006 Aug;61(8):859-65
pubmed: 16912105
Nature. 2010 Mar 25;464(7288):529-35
pubmed: 20336135
J Prev Alzheimers Dis. 2016 Mar;3(1):53-64
pubmed: 26900574
J Gerontol B Psychol Sci Soc Sci. 2011 Jul;66 Suppl 1:i162-71
pubmed: 21743047
Neuroepidemiology. 2007;29(1-2):66-73
pubmed: 17925596
Neurobiol Aging. 2018 Nov;71:189-222
pubmed: 30172220
Arch Neurol. 2009 Nov;66(11):1339-44
pubmed: 19901164
N Engl J Med. 2013 Apr 4;368(14):1326-34
pubmed: 23550670
Age Ageing. 2011 Sep;40(5):630-3
pubmed: 21791447
Expert Rev Neurother. 2011 May;11(5):665-76
pubmed: 21539487
Alzheimers Dement. 2008 Mar;4(2):134-44
pubmed: 18631957
Neurosci Biobehav Rev. 2010 Apr;34(5):721-33
pubmed: 19850077
J Phys Ther Sci. 2015 Dec;27(12):3911-5
pubmed: 26834379
Front Aging Neurosci. 2018 Nov 15;10:341
pubmed: 30498440
J Bone Metab. 2017 May;24(2):83-89
pubmed: 28642851
Int Psychogeriatr. 1999 Jun;11(2):139-48
pubmed: 11475428
Alzheimers Dement. 2019 Jan;15(1):17-24
pubmed: 30243772
Sports Med. 2018 Sep;48(9):1993-2000
pubmed: 29943230
Clin Geriatr Med. 2013 Nov;29(4):873-93
pubmed: 24094301

Auteurs

Ryan McGrath (R)

Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA.

Sheria G Robinson-Lane (SG)

School of Nursing, University of Michigan, Ann Arbor, MI, USA.

Summer Cook (S)

Department of Kinesiology, University of New Hampshire, Durham, NH, USA.

Brian C Clark (BC)

Ohio Musculoskeletal and Neurological Institute, Ohio University, Athens, OH, USA.
Department of Biomedical Sciences, Ohio University, Athens, OH, USA.
Department of Geriatric Medicine, Ohio University, Athens, OH, USA.

Stephen Herrmann (S)

Sanford Research, Sioux Falls, SD, USA.

Melissa Lunsman O'Connor (ML)

Department of Human Development and Family Science, North Dakota State University, Fargo, ND, USA.

Kyle J Hackney (KJ)

Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH